Dr. Christine Roussel is a Board Certified Oncology Pharmacist with a Bachelors in Toxicology and Doctorate in Pharmacy from Philadelphia College of Pharmacy. She is Director of Pharmacy at Doylestown Hospital (Pennsylvania), Adjunct Assistant Professor at USciences, facilitator for LP3 Network, and consultant for MEDISCA Network. On top of her day job of overseeing the clinical and operational aspects of patient care, she provides over 100 hours of education to pharmacists, physicians, and nurses each year. Dr. Roussel focuses on occupational exposure to hazardous drugs, sterile/non-sterile compounding, clinical and legislative topics, such as medical cannabis, opioid stewardship, drug diversion prevention, pharmaceutical waste and contamination. She is a consultant for cleanroom facility design. She has authored articles on occupational exposure to hazardous drugs, as protecting healthcare providers’ DNA is her primary passion! Her most recent publication is: Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs. In 2018 she was nationally recognized as “40 Under 40 in Oncology”
She is active in many professional organizations including, Delegate for the American Society of Health Systems Pharmacy, President Elect for Pennsylvania Society of Health Systems Pharmacy, Board of Directors for International Society of Cannabis Pharmacists, American Industrial Hygiene Association, and the Association for Compounding Pharmacists (ACP).
Outside of work, Dr. Roussel is a dedicated mother, Cub Scout leader, and enjoys teaching her kids about engineering, often in the form of marshmallow propulsion devices and rocket building!